hims glp-1 news Full Range of FDA-Approved GLP-1s Available on & Hers Hims' copycat GLP-1 gamble backfires

Conflict of interest AV is an investigator in an investigator-initiated study sponsored by Novo Nordisk

By modulating dopamine pathways in the brain, these medications could help reduce cravings and compulsive behaviours across a spectrum of addictions

In November 2023, a new GLP-1, called tirzepatide (Zepbound, Mounjaro), was approved for weight loss and obesity management

PlexusDx's Precision Peptide Genetic Test maps 14 distinct pathways and analyzes 150+ genetic insights across 49 peptides involved in weight regulation and metabolism

Previous studies found that even major life events, a diabetes diagnosis, job loss, childbirth, produce only modest and short-lived changes in diet

If GI symptoms are manageable, continue at this dose for the full four weeks before considering the next increase